BirchBioMed Inc. — Form D/A

BirchBioMed Inc. of KING CITY, A6, a company, filed a Form D amendment with the SEC on 2025-10-01. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Teresa BairDirectorKing City, A6
Susan ElliottDirectorKing City, A6
Charles EllisDirectorKing City, A6
Mark MillerDirectorMcCall, ID
Joseph SardanoDirectorKing City, A6
Carlos CamozziExecutive OfficerKing City, A6
Susan ElliottExecutive OfficerKing City, A6
Herve GirsaultExecutive OfficerKing City, A6
Mark MillerExecutive OfficerMcCall, ID
John VerbeckExecutive OfficerKing City, A6
Susan ElliottPromoterKing City, A6
Mark MillerPromoterMcCall, ID
Joseph C SardanoDirectorKing City, A6
Jon M VerbeckExecutive OfficerKing City, A6
Charles N EllisDirectorKing City, A6
Susan M ElliottDirectorKing City, A6
Susan M ElliottExecutive OfficerKing City, A6
Susan M ElliottPromoterKing City, A6
Teresa S BairDirectorKing City, A6
Teresa S BairExecutive OfficerKing City, A6
Teresa S BairPromoterKing City, A6
Mark S MillerDirectorKing City, A6
Mark S MillerExecutive OfficerKing City, A6
Mark S MillerPromoterKing City, A6
Ryan V HartwellDirectorKing City, A6

Other filings by this issuer (7)

FiledFormOfferingSold
2025-07-11D$3.0M$175K
2021-11-01D$2.9M$596K
2020-08-28D$2.9M$399K
2020-02-05D/A$10.0M$5.3M
2019-02-25D/A$10.0M$4.0M
2017-09-20D/A$10.0M$1.4M
2016-03-30D$10.0M

More